Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

April 2, 2025
Uganda launches Africa’s largest malaria vaccine rollout to date
March 25, 2025
Fewer shots, more protection: The promise of combination vaccines
March 20, 2025
How local heroes are reshaping disability care in Mozambique

Stay informed with PATH Insights

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
February 8, 2024
Good intentions, bad outcomes: The dangers of donated medical devices
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. The looming antibiotic emergency and why the time for global action is now
    PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  2. PATH part of $12.7M GHIT Fund initiative for malaria, NTDs research.
    PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
  3. Opinion: GenAI for global health — the bear and the bull case
    Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  4. Life-saving advances in vaccines pave the way for healthier futures
    Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

948 Item s
948 Item s
    Date
    From
    To
  1. Next generation pulse oximeters have great potential to reduce maternal and child mortality, PATH and Unitaid report says
    A technology and market landscape report by PATH and Unitaid
    Published: September 2022
    Press Release
  2. Serving Life project transitions innovative HIV service delivery models to Ukrainian government for institutionalization and scale-up
    The PATH-led USAID/PEPFAR Serving Life project introduced, scaled, and successfully transitioned an integrated, person-centered package of comprehensive health services in prison and community settings to enhance the delivery of testing and treatment services among key populations in Ukraine.
    Published: September 2022
    Press Release
  3. PATH applauds the establishment of new fund for pandemic prevention, preparedness, and response
    Published: September 2022
    Press Release
  4. P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing
    MedAccess, PATH, and SD Biosensor announce a new partnership aimed at advancing progress towards the elimination of P. vivax malaria. The partnership will increase access to G6PD testing, which provides doctors with essential information to prescribe the safest, most effective course of treatment for P. vivax malaria patients.
    Published: September 2022
    Press Release
  5. PATH’s Chief Scientific Officer accepts role with FDA agency, CBER
    Published: September 2022
    Announcement
Previous
Next